Skip to main content

Table 8 Relation between type of authorization and effectiveness

From: Oncologic orphan drugs approved in the EU – do clinical trial data correspond with real-world effectiveness?

  Effectiveness  
Survival benefit > 3 months Survival benefit < 3 months, unknown magnitude or no benefit Total
Authorization Full 3 1 4
Conditional or exceptional 3 3 6
  Total 6 4 10